chr1-159928710-C-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001135050.2(IGSF9):c.2678G>A(p.Gly893Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000194 in 1,476,806 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001135050.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152126Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000499 AC: 48AN: 96162 AF XY: 0.000373 show subpopulations
GnomAD4 exome AF: 0.000181 AC: 240AN: 1324564Hom.: 2 Cov.: 35 AF XY: 0.000187 AC XY: 121AN XY: 645350 show subpopulations
GnomAD4 genome AF: 0.000302 AC: 46AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74432 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2678G>A (p.G893E) alteration is located in exon 19 (coding exon 18) of the IGSF9 gene. This alteration results from a G to A substitution at nucleotide position 2678, causing the glycine (G) at amino acid position 893 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at